Ozer Z - Search Results

1

One-Step, Rapid, ¹⁸F-¹⁹F Isotopic Exchange Radiolabeling of Difluoro-dioxaborinins: Substituent Effect on Stability and In Vivo Applications.

An F, Nurili F, Sayman H, Ozer Z, Cakiroglu H, Aras O, Ting R. An F, et al. Among authors: ozer z. J Med Chem. 2020 Nov 12;63(21):12693-12706. doi: 10.1021/acs.jmedchem.0c00997. Epub 2020 Oct 21. J Med Chem. 2020. PMID: 32787084 Free PMC article.

2

Anti-inflammatory activity profile of JANEX-1 in preclinical animal models.

Uckun FM, Tibbles H, Ozer Z, Qazi S, Vassilev A. Uckun FM, et al. Among authors: ozer z. Bioorg Med Chem. 2008 Feb 1;16(3):1287-98. doi: 10.1016/j.bmc.2007.10.066. Epub 2007 Oct 24. Bioorg Med Chem. 2008. PMID: 18024136

3

Structure-based design and engineering of a nontoxic recombinant pokeweed antiviral protein with potent anti-human immunodeficiency virus activity.

Uckun FM, Rajamohan F, Pendergrass S, Ozer Z, Waurzyniak B, Mao C. Uckun FM, et al. Among authors: ozer z. Antimicrob Agents Chemother. 2003 Mar;47(3):1052-61. doi: 10.1128/AAC.47.3.1052-1061.2003. Antimicrob Agents Chemother. 2003. PMID: 12604541 Free PMC article.

4

Bruton's tyrosine kinase prevents activation of the anti-apoptotic transcription factor STAT3 and promotes apoptosis in neoplastic B-cells and B-cell precursors exposed to oxidative stress.

Uckun F, Ozer Z, Vassilev A. Uckun F, et al. Among authors: ozer z. Br J Haematol. 2007 Feb;136(4):574-89. doi: 10.1111/j.1365-2141.2006.06468.x. Br J Haematol. 2007. PMID: 17367410 Free article.

5

Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex.

Vassilev A, Ozer Z, Navara C, Mahajan S, Uckun FM. Vassilev A, et al. Among authors: ozer z. J Biol Chem. 1999 Jan 15;274(3):1646-56. doi: 10.1074/jbc.274.3.1646. J Biol Chem. 1999. PMID: 9880544 Free article.

6

Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells.

Mahajan S, Vassilev A, Sun N, Ozer Z, Mao C, Uckun FM. Mahajan S, et al. Among authors: ozer z. J Biol Chem. 2001 Aug 17;276(33):31216-28. doi: 10.1074/jbc.M104874200. Epub 2001 Jun 18. J Biol Chem. 2001. PMID: 11413148 Free article.

7

A PREVIOUSLY UNKNOWN UNIQUE CHALLENGE FOR INHIBITORS OF SYK ATP-BINDING SITE: ROLE OF SYK AS A CELL CYCLE CHECKPOINT REGULATOR.

Uckun FM, Ma H, Ozer Z, Goodman P, Zhang J, Qazi S. Uckun FM, et al. Among authors: ozer z. EBioMedicine. 2014 Nov 1;1(1):16-28. doi: 10.1016/j.ebiom.2014.10.019. EBioMedicine. 2014. PMID: 25506060 Free PMC article.

8

KU HAPLOINSUFFIENCY CAUSES A LYMPHOPROLIFERATIVE DISORDER OF IMMATURE T-CELL PRECURSORS DUE TO IKAROS MALFUNCTION.

Ozer Z, Qazi S, Ishkhanian R, Hasty P, Ma H, Uckun FM. Ozer Z, et al. Int J Mol Med Sci. 2013 Jun 21;3(7):50-64. doi: 10.5376/ijmms.2013.03.0007. Int J Mol Med Sci. 2013. PMID: 24478815 Free PMC article.

9

Recombinant human CD19-ligand protein as a potent anti-leukaemic agent.

Uckun FM, Sun L, Qazi S, Ma H, Ozer Z. Uckun FM, et al. Among authors: ozer z. Br J Haematol. 2011 Apr;153(1):15-23. doi: 10.1111/j.1365-2141.2011.08583.x. Epub 2011 Feb 17. Br J Haematol. 2011. PMID: 21323891 Free article.

10

Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network.

Uckun FM, Qazi S, Ozer Z, Garner AL, Pitt J, Ma H, Janda KD. Uckun FM, et al. Among authors: ozer z. Br J Haematol. 2011 Jun;153(6):741-52. doi: 10.1111/j.1365-2141.2011.08671.x. Epub 2011 Apr 25. Br J Haematol. 2011. PMID: 21517817 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters